Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2000
03/14/2000US6037351 Method of inhibiting hepatitis B virus
03/14/2000US6037350 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quionlinone derivatives
03/14/2000US6037348 Inhibition of viral replication
03/14/2000US6037347 Comprising a compound which has an acetylcholinesterase-inhibitory action or exhibits muscarinergic action and a compound which increases the endogenous extracellular adenosine level
03/14/2000US6037346 Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
03/14/2000US6037345 Method for inhibiting neoplastic cells and related conditions by exposure to quinazolinedione and pyridopyrimidinedione derivatives
03/14/2000US6037343 Fibrinogen receptor antagonists
03/14/2000US6037342 Serotonin 5-HT3 receptor partial activator
03/14/2000US6037341 Carbapenem derivatives
03/14/2000US6037339 C-11 substituted steroids for treating menopausal complaints
03/14/2000US6037337 Use of the enantiomers of ifosfamide in antitumor therapy for reducing side effects
03/14/2000US6037334 Inhibitors of factor xa that can be used to prevent diseases such asthrombosis, apoplexy, coronary infarction, inflammations, and arteriosclerosis
03/14/2000US6037333 Microbe-inhibiting compositions
03/14/2000US6037332 Method of urinary bladder instillation
03/14/2000US6037331 Compositions for prevention of inflammation and adhesion formation uses thereof
03/14/2000US6037327 Specific saccharide compositions and methods for treating Alzheimer's disease and other amyloidoses
03/14/2000US6037326 Applying to the skin an inhibitor of a dna topoisomerase
03/14/2000US6037324 Madcam-1 (mucosal addressin cell adhesion molecule-1); useful in the treatment of inflammatory bowel diseases and other diseases involving leukocyte infiltration of the gastrointestinal tract or other mucosal tissues
03/14/2000US6037157 Method for improving pharmacokinetics
03/14/2000US6037149 Nucleotide sequence coding human interleukin-9; for the diagnosis of sensitivity to allergy and asthma
03/14/2000US6037146 CDNA clone HE8CH90 that encodes a novel 7-transmembrane receptor
03/14/2000US6036992 Process of making an enteral formula containing long-chain polyunsaturated fatty acids
03/14/2000US6036975 Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof
03/14/2000US6036973 Therapy for neurological diseases
03/14/2000US6036126 Apparatus for separating particles of cohesive material according to size and process
03/14/2000CA2282147A1 Immunosuppresive agents
03/14/2000CA2281852A1 An antifungal lactone compound
03/14/2000CA2195213C Use of droloxifene for the treatment of cardiovascular diseases
03/14/2000CA2184919C New piperazine derivatives and methods for the preparation thereof and compositions containing the same
03/14/2000CA2132424C Antisense oligonucleotide inhibition of papillomavirus
03/14/2000CA2117643C Indole derivatives
03/14/2000CA2098483C Safe adeno-associated virus 2 vector for gene therapy
03/14/2000CA2097285C Thienodiazepine compounds and their use
03/14/2000CA2071205C Cell surface antigen associated with cellular apoptosis
03/14/2000CA2013188C Preservative system for ophthalmic formulations
03/14/2000CA2009542C Cyclic guanidines as calcium antagonists
03/14/2000CA2008263C Pyrazolopyridine compound and processes for preparation thereof
03/14/2000CA2007367C Process and composition for the purification of amphotericin b
03/09/2000WO2000013029A1 Method for evaluating lipid a analog-containing injections
03/09/2000WO2000013015A1 Modulating multiple lineage kinase proteins
03/09/2000WO2000012737A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
03/09/2000WO2000012720A2 Elongase genes and uses thereof
03/09/2000WO2000012718A1 Superoxide dismutase as a vaccine antigen
03/09/2000WO2000012710A1 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same
03/09/2000WO2000012709A2 Phelix: a testis-specific protein expressed in cancer
03/09/2000WO2000012686A1 Expression systems for functional nucleic acid expression
03/09/2000WO2000012685A2 Genes associated with neurotransmitter processing
03/09/2000WO2000012679A1 Novel ubiquitin ligases as therapeutic targets
03/09/2000WO2000012623A2 Use of 5-th receptor antagonists for the treatment of parkinson's disease
03/09/2000WO2000012551A1 HUMAN LATENT TRANSFORMING GROWTH FACTOR-β BINDING PROTEIN 3
03/09/2000WO2000012535A2 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
03/09/2000WO2000012534A2 A method of inhibiting formation of infectious herpes virus particles
03/09/2000WO2000012531A1 Ratc
03/09/2000WO2000012525A1 Sequences characteristic of hypoxia-regulated gene transcription
03/09/2000WO2000012519A1 Phosphoepoxides, method for making same and uses
03/09/2000WO2000012517A1 Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof
03/09/2000WO2000012516A1 Phosphohalohydrins, method for making same and uses
03/09/2000WO2000012514A1 Novel compounds
03/09/2000WO2000012512A1 Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them
03/09/2000WO2000012510A1 Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists
03/09/2000WO2000012509A2 Collections of compounds
03/09/2000WO2000012508A2 Pyrrolbenzodiazepines
03/09/2000WO2000012507A2 Pyrrolobenzodiazepines
03/09/2000WO2000012506A2 Collections of compounds
03/09/2000WO2000012505A2 Triazolopyridazine derivatives for treating anxiety and enhancing cognition
03/09/2000WO2000012504A2 Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one
03/09/2000WO2000012502A1 Pyrroloquinolines for treatment of obesity
03/09/2000WO2000012501A1 Benzonaphthyridine-n-oxides comprising a pde3 and pde4 inhibiting activity
03/09/2000WO2000012499A1 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents
03/09/2000WO2000012498A1 Quinolin-2-one derivatives useful as anticancer agents
03/09/2000WO2000012497A2 Quinazoline derivatives as medicaments
03/09/2000WO2000012496A1 Novel cdk inhibitors having flavone structure
03/09/2000WO2000012494A1 Apoptosis inducing agents
03/09/2000WO2000012493A1 Thiazoline acid derivatives
03/09/2000WO2000012489A1 1, 2, 4-triazole-3-thione compounds
03/09/2000WO2000012488A1 Pyrazine compounds
03/09/2000WO2000012486A1 Pyrimidine compounds
03/09/2000WO2000012485A1 Pyrimidine compounds
03/09/2000WO2000012484A1 Tan-1057 derivatives
03/09/2000WO2000012483A1 Triptolide prodrugs having high aqueous solubility
03/09/2000WO2000012481A2 Indazole derivatives with 5-ht2 receptor activity________________
03/09/2000WO2000012479A1 2-oxo-2h-quinoline derivatives
03/09/2000WO2000012478A1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp)
03/09/2000WO2000012477A1 Hydroxamic acid derivatives as proteinase inhibitors
03/09/2000WO2000012475A1 Indoline derivatives as 5-ht2b and/or 5-ht2c receptor ligands
03/09/2000WO2000012467A1 N-hydroxyacylamino compounds, process for their preparation and pharmaceutical compositions containing them
03/09/2000WO2000012462A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
03/09/2000WO2000012175A2 Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases
03/09/2000WO2000012170A1 Gelatinous body protection article having a therapeutic additive
03/09/2000WO2000012139A1 Hypoxia regulated genes
03/09/2000WO2000012133A1 Neisseria spp. polypeptide, nucleic acid sequence and uses thereof
03/09/2000WO2000012110A2 Use of anti(w)pressor agents for vascular remodeling in genital dysfunction
03/09/2000WO2000012107A1 Composition containing pyrrolizidine-alkaloid-free petasites
03/09/2000WO2000012106A1 Gabab1aa receptor
03/09/2000WO2000012101A2 Use of selenium for treating patients suffering from systemic inflammatory response syndrome (sirs), and composition for implementing said treatment
03/09/2000WO2000012100A1 Inherently antimicrobial quaternary amine hydrogel wound dressings
03/09/2000WO2000012099A1 Promoters of neural regeneration
03/09/2000WO2000012098A1 Medicinal compositions for treating eye diseases
03/09/2000WO2000012097A1 Controlled release tablet comprising a hypoglycemic drug and an antihyperglycemic drug
03/09/2000WO2000012095A1 Chromium polynicotinate compositions and uses thereof
1 ... 6350 6351 6352 6353 6354 6355 6356 6357 6358 6359 6360 6361 6362 6363 6364 6365 6366 6367 6368 6369 6370 ... 7860